Fundz

Fundz Deep Dive

Everything you need to win Tessara Therapeutics Psylo and the University of Sydney — in one platform.

Who to reach, what to say, and why now on Tessara Therapeutics Psylo and the University of Sydney — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Tessara Therapeutics Psylo and the University of Sydney — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

$3M Partnership to Accelerate Development of Neuroplastogens for Substance Use Disorder Treatment

Oct 28, 2024over 1 year ago

Contract Type

partnership

BoulderBiotechnologyHealth CareTherapeutics

Description

Tessara Therapeutics, Psylo, and the University of Sydney have secured a $3 million grant to advance brain-rewiring treatments for addiction. The collaboration will focus on the development of neuroplastogens for the treatment of substance use disorders, with an emphasis on methamphetamine addiction, aiming to provide faster, more effective treatments for addiction and other mental health conditions.

Company Information

Company

Tessara Therapeutics Psylo and the University of Sydney

Location

Boulder, Colorado, United States

About

Tessara Therapeutics, Psylo, and the University of Sydney are collaborating to develop neuroplastogens for the treatment of substance use disorders, with a focus on methamphetamine addiction.

Predictive Intelligence
Strategic

ML-powered predictions for Tessara Therapeutics Psylo and the University of Sydney's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.